BetterScholar BetterScholar
7
Role
Title
Level Year L/R
🐜 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial
334 auth. X. Pivot, G. Romieu, M. Debled, J. Pierga, P. Kerbrat, T. Bachelot, A. Lortholary, M. Espié, P. Fumoleau, D. Serin, J. Jacquin, C. Jouannaud, M. Rios, S. Abadie-Lacourtoisie, L. Venat-Bouvet, ... L. Cany, S. Catala, D. Khayat, L. Gambotti, I. Pauporté, C. Faure-Mercier, S. Paget‐Bailly, J. Henriques, J. Grouin, C. Piprot, L. Cals, L. Chaigneau, F. Demarchi, T. N'guyen, U. Stein, C. Villanueva, J. Breau, A.K. Chouahnia, P. Saintigny, F. Boué, P. deSaint-Hilaire, I. Guimont, N. Grossat, B. Valenza, E. Levy, J. Medioni, C. Delbaldo, J. Grenier, D. Pouessel, S. Lavau-Denès, C. Falandry, C. Fournel-Federico, G. Freyer, S. Tartas, V. Trillet-Lenoir, F. Bons, G. Auclerc, S. Chièze, N. Raban, C. Tournigand, S. Trager-Maury, G. Bousquet, C. Cuvier, S. Giacchetti, A. Hocini, C. Lemaignan, J. Misset, D. Avenin, C. Beerblock, J. Gligorov, P. Rivera, H. Roché, P. Bougnoux, N. Hajjaji, O. Capitain, R. Delva, P. Maillart, P. Soulié, H. Bonnefoi, M. Durand, N. Madranges, L. Mauriac, P. Chollet, A. Dillies, X. Durando, JP Ferrière, C. Mouret-Reynier, JM Nabholtz, I. V. Praagh, P. Cottu, V. Diéras, A. Durieux, M. Galotte, V. Girre, S. Henry, I. Iurisci, M. Jouve, V. Laurence, L. Mignot, S. Piperno-Neumann, P. Tresca, B. Coudert, E. Ferrant, F. Mayer, A. Vanneuville, J. Bonneterre, V. Servent, L. Vanlemmens, P. Vennin, J. Guastalla, P. Biron, L. Dupuy-Brousseau, L. Lancry, I. Ray-Coquard, P. Rebattu, O. Trédan, JM Extra, F. Rousseau, C. Tarpin, M. Fabbro, É. Luporsi, L. Uwer, B. Weber, D. Berton-Rigaud, E. Bourbouloux, M. Campone, J. Ferrero, P. Follana, R. Largillier, V. Mari, B. Costa, H. Curé, J. Eymard, N. Jovenin, D. Lebrun, J. Meunier, G. Yazbek, D. Gedoin, B. Laguerre, C. Lefeuvre, E. Vauléon, A. Chevrier, C. Guillemet, M. Leheurteur, O. Rigal, I. Tennevet, C. Veyret, E. Brain, M. Guiterrez, F. Mefti-Lacheraf, T. Petit, F. Dalenc, L. Gladieff, F. Andre, S. Delaloge, J. Dômont, J. Ezenfis, M. Spielmann, P. Guillet, V. Boulanger, J. Provençal, L. Stefani, C. Alliot, D. Ré, C. Bellaiche-Miccio, G. Boutan-Laroze, R. Vanica, P. Dion, G. Sadki-Benaoudia, A. Marti, A-L. Villing, B. Slama, JL Dutel, S. Nguyen, R. Saad, O. Arsène, Z. Merad-Boudia, H. Orfeuvre, J. Egreteau, MJ Goudier, R. Lamy, B. Leduc, C. Sarda, B. Salles, C. Agostini, I. Cauvin, A. Dufresne, M. Mangold, S. Lebouvier-Sadot, B. Audhuy, J. Barats, S. Cluet-Dennetiere, D. Zylberait, G. Netter, L. Gautier-Felizot, I. Cojean-Zelek, A. Plantade, S. Vignot, E. Guardiola, P. Marti, I. deHartingh, R. Diab, A. Dietmann, S. Ruck, C. Portois, S. Oddou-Lagranière, F. Campos-Gazeau, A. Bourcier, F. Priou, JF Geay, D. Mayeur, P. Gabez, R. Elamarti, M. Combe, P. Raichon-Patru, P. Amsalhem, J. Dauba, D. Paraiso, F. Guinet, B. Duvert, M. Litor, F. Kara-Slimane, A. Bichoffe, N. Denizon, P. Soyer, F. Morvan, S. Van-Hulst, L. Vincent, C. Alleaume, P. Ibáñez-Martín, A. Youssef, Z. Tadrist, E. Carola, C. Pourny, JF Toccanier, N. Al-Aukla, K. Mahour-Bacha, J. Salvat, P. Nouyrigat, S. Clippe, M C Gouttebel, L. Vedrine, G. Clavreul, O. Collard, D. Mille, Y. Goubely, R. Hervé, S. Kirscher, F. Plat, V. Delecroix, V. Ligeza-Poisson, D. Coeffic, D. Fric, C. Garnier, C. Leyronnas, T. Kreitman, E. Teissier, P. Martin, S. R. deCordoue, C. Elkouri, JF Ramée, C. Laporte, O. Bernard, T. Altwegg, A. Darut‐Jouve, JP Dujols, F. Darloy, C. Giraud, V. Pottier-Kyndt, N. Achour, S. Drony, M. Moriceau, C. Sarrazin, JC Legueul, J. Mandet, D. Besson, A. Hardy-Bessard, J. Cretin, P. Houyau, E. Achille, D. Genet, H. Thévenot, A. Moran-Ribon, JM Pavlovitch, P. Ardisson, I. Moullet, B. Couderc, V. Fichet, F. Burki, A. Auliard, C. Levache, P. Cailleux, F. Schaeffer, N. Albin, D. Sevin-Robiche, J. Domas, S. Ellis, P. Montcuquet, G. Baumont, M. Begue, S. Greget, J. Ratoanina, A. Vanoli, C. Bielsa, M. Bonichon-Lamichhane, D. Jaubert, H. Laharie-Mineur, L. Alcaraz, E. Legouffe, H. Bourgeois, G. Cartron, F. Denis, O. Dupuis, G. Ganem, S. Roche-Forestier, L. Delzenne, E. Chirat, J. Baticle, E. Beguier, S. Jacquot, E. Janssen, H. Lauche, A. Lerol, JP Chantelard, G. L'helgoualc'h, E. Antoine, A. Kanoui, JF Llory, J.-M. Vannetzel, J. Vignoud, C. Bruna, T. Facchini, K. Moutel-Corviole, A. Voloch, A. Ghoul, D. Loiseau, N. Barbet, N. Dohollou, K. Yakendji
6 2019
6
🐜
🐜 Incidence of Venous Thromboembolism in Patients with Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
88 auth. Corinne Frère, B. Bournet, S. Gourgou, J. Fraisse, C. Canivet, J. Connors, L. Buscail, D. Farge, N. Carrère, F. Muscari, B. Suc, R. Guimbaud, C. Couteau, M. Deslandres, P. Rivera, ... A. Laurenty, N. Farés, K. Barange, J. Selves, A. Gomez-Brouchet, B. Napoléon, B. Pujol, F. Fumex, J. Desramé, C. Lefort, V. Lépilliez, R. Gincul, P. Artru, L. Clavel, A. LeMaistre, Lauren L Palazzo, J. Cros, Sarah Tubiana, N. Flori, P. Senesse, P. Colombo, Emmanuelle Samail-Scalzi, F. Portales, S. Gourgou, Claire Honfo Ga, C. Plassot, F. Bibeau, M. Ychou, P. Guibert, C. Fouchardiere, M. Sarabi, P. Peyrat, S. Tabone-Eglinger, C. Renard, G. Piessen, S. Truant, A. Saudemont, G. Millet, F. Renaud, E. Leteurtre, P. Gele, E. Assenat, J. Fabre, F. Souche, Marie Dupuy, Anne-Marie Gorce-Dupuy, J. Ramos, J. Seitz, J. Hardwigsen, E. Norguet-Monnereau, P. Grandval, M. Duluc, D. Figarella-Branger, V. Vendrely, C. Subtil, É. Terrebonne, J. Blanc, E. Buscail, J. Merlio, J. Gornet, D. Geromin, G. Vanbiervliet, A. Frin, Delphine Ouvrier, M. Saint‐Paul, P. Berthélemy, Chelbabi Fouad, S. Garcia, N. Lesavre, M. Gasmi, M. Barthet, V. Cottet, C. Delpierre
5 2019
5
🐜
🐜 Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study.
16 auth. X. Pivot, Jean-Philippe Spano, M. Espié, P. Cottu, C. Jouannaud, V. Pottier, L. Moreau, J. Extra, Alain Lortholary, P. Rivera, ... Dominique Spaeth, H. Attar-rabia, Chahinez Benkanoun, L. Dima-Martinez, N. Esposito, J. Gligorov
5 2017
5
🐜
🐜 Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer.
18 auth. X. Pivot, J. Spano, M. Espié, C. Jouannaud, Valérie Pottier, Laura Moreau, J. Extra, A. Lortholary, P. Rivera, D. Spaeth, ... Z. Mouri, Fella Tariket, J. Dupin, Aurelien Berthois, M. Ionescu-Goga, Abdennour Ferhat, P. Cottu, J. Gligorov
2 2023
2
🐜
🦁 Efficacy of cetuximab plus platinum agent in advanced, triple-negative breast carcinoma: Results of a retrospective analysis.
7 auth. P. Rivera, T. Filleron, L. Gladieff, J. Delord, E. Mery, H. Roché, ... F. Dalenc
2 2011
2
🦁
🐜 Hepatic Arterial Infusion Chemotherapy With Folfirinox or Oxaliplatin Alone in Metastatic Colorectal Cancer
14 auth. V. Randrian, S. Pernot, B. Sionneau, Denis Smith, A. Lim, Y. Touchefeu, C. Gallois, A. Turpin, S. Javed, R. Guimbaud, ... P. Rivera, M. Karoui, E. Auclin, J. Taieb
1 2022
1
🐜
🐜 Hepatic Arterial Infusion (HAI) of Oxaliplatin Plus Intravenous (IV) Fluorouracil (FU), Leucovorin (LV) and Cetuximab for First-Line Treatment of Unresectable Colorectal Liver Metastases (CRLM): Final Results of a Multicenter Phase 2 Study (CHOICE)
10 auth. D. Malka, V. Boige, M. Faron, C. Caramella, E. Boucher, P. Rivera, ... T. Baère, D. Goéré, J. Pignon, M. Ducreux
0 2012
0
🐜